Table 3

Estimated PK parameters

CompoundCompCl, mL/h per kgV1, mL/kgV2, mL/kgt1/2 alfa, ht1/2 beta, hMRT, h
FVII 609 304 336 0.19 1.4 1.0 
FVII_X 176 244 966 0.10 6.3 6.6 
FX 25 105 102 0.08 8.6 6.3 
FXai 354 216   0.42 0.6 
FVII_XHC 82 194 305 0.12 5.4 5.5 
FVII_X1-34 249 228 490 0.15 3.6 2.6 
FVII_X30-52 295 246 1080 0.13 4.2 4.4 
FVII_XNNAA 115 173 259 0.16 3.8 3.4 
FVII_XTTAA 146 200 747 0.11 5.7 6.3 
CompoundCompCl, mL/h per kgV1, mL/kgV2, mL/kgt1/2 alfa, ht1/2 beta, hMRT, h
FVII 609 304 336 0.19 1.4 1.0 
FVII_X 176 244 966 0.10 6.3 6.6 
FX 25 105 102 0.08 8.6 6.3 
FXai 354 216   0.42 0.6 
FVII_XHC 82 194 305 0.12 5.4 5.5 
FVII_X1-34 249 228 490 0.15 3.6 2.6 
FVII_X30-52 295 246 1080 0.13 4.2 4.4 
FVII_XNNAA 115 173 259 0.16 3.8 3.4 
FVII_XTTAA 146 200 747 0.11 5.7 6.3 

NMRI mice were dosed 1 mg/kg of the listed compounds intravenously.

Comp indicates the estimated number of compartments in the pharmacokinetic model; Cl, clearance; V1, central compartment; V2, peripheral compartment; t1/2alpha, distribution half-life; t1/2beta, terminal half-life; and MRT, mean residence time.

Close Modal

or Create an Account

Close Modal
Close Modal